Liu Ziyi, He Mingxing, Zhao Qiuyun, Tang Ying, Xu Chenggang
Key Laboratory of Applied Biotechnology on Animal Science & Veterinary Medicine of Zhejiang Province, Zhejiang Engineering Research Center for Veterinary Diagnostics & Advanced Technology, Zhejiang International Science and Technology Cooperation Base for Veterinary Medicine and Health Management, Belt and Road International Joint Laboratory for One Health and Food Safety, China-Australia Joint Laboratory for Animal Health Big Data Analytics, College of Veterinary Medicine of Zhejiang A&F University, 666 Wusu Street, Lin'an District, Hangzhou, 311300, Zhejiang Province, China.
Vet Res Commun. 2025 Aug 8;49(5):276. doi: 10.1007/s11259-025-10854-1.
The emergence of Paraclostridium bifermentans as a human pathogen has garnered increasing attention. However, due to the challenges associated with isolation, there remains a scarcity of relevant clinical isolates and genomic information. Here, we isolated two P. bifermentans strains PB29 and PB30 from the fecal samples of Hu sheep, characterized the virulence phenotypes, and conducted a comparative genomic analysis to illustrate the evolutionary pathway and distribution of carbohydrate active enzymes (CAZymes). The results indicated that both isolates exhibited substantial phospholipase C and hemolytic activities, while sharing a close phylogenetic relationship. Moreover, strains of P. bifermentans belonging to the same evolutionary lineage as PB29 and PB30 harbor a greater number of virulence factors than strains from other lineages, with the majority originating from the intestine environment. This observation suggests that this lineage has the potential to clonally spread within the gut and evolve into a representative pathogen. Furthermore, P. bifermentans commonly shares mucin degradation carbohydrate hydrolases (GHs) GH2, GH20, and GH73. They also exhibit conserved CAZymes, such as GT4, GT5, CE4, and CE5, which enable them to efficiently metabolize complex carbohydrates and adapt to diverse ecological niches. Overall, these findings offer valuable genomic insights into the potential role of P. bifermentans as an intestinal pathogen.
双发酵副梭菌作为一种人类病原体的出现已引起越来越多的关注。然而,由于与分离相关的挑战,相关临床分离株和基因组信息仍然匮乏。在此,我们从湖羊粪便样本中分离出两株双发酵副梭菌菌株PB29和PB30,对其毒力表型进行了表征,并进行了比较基因组分析,以阐明碳水化合物活性酶(CAZymes)的进化途径和分布。结果表明,这两株分离株均表现出大量的磷脂酶C和溶血活性,同时具有密切的系统发育关系。此外,与PB29和PB30属于同一进化谱系的双发酵副梭菌菌株比其他谱系的菌株具有更多的毒力因子,其中大多数起源于肠道环境。这一观察结果表明,该谱系有可能在肠道内克隆传播并进化成为一种典型病原体。此外,双发酵副梭菌通常共享粘蛋白降解碳水化合物水解酶(GHs)GH2、GH20和GH73。它们还表现出保守的CAZymes,如GT4、GT5、CE4和CE5,这使它们能够有效地代谢复杂碳水化合物并适应不同的生态位。总体而言,这些发现为双发酵副梭菌作为肠道病原体的潜在作用提供了有价值的基因组见解。